A long‐term survivor keeping in a complete response without treatment after pemetrexed maintenance therapy for advanced non‐squamous non‐small cell lung cancer

A long‐term survivor keeping in a complete response without treatment after pemetrexed maintenance therapy for advanced non‐squamous non‐small cell lung cancer

Pemetrexed has significant efficacy for some non‐squamous non‐small cell lung cancer cases, as demonstrated in the current case. For those patients, pemetrexed administration should be carefully considered. Pemetrexed has significant efficacy for some non‐squamous non‐small cell lung cancer cases, a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical case reports 2021-02, Vol.9 (2), p.927-931
Hauptverfasser: Furugen, Makoto, Shibahara, Daisuke, Kiyuna, Tomo, Kami, Wakaki, Miyagi, Kazuya, Haranaga, Shusaku, Kubota, Toru, Matsumoto, Hirofumi, Yoshimi, Naoki, Fujita, Jiro
Format: Artikel
Sprache:eng
Schlagworte:
Biopsy
Cancer therapies
Case Report
Case Reports
Chemotherapy
complete response
Conflicts of interest
cytotoxic drug
Cytotoxicity
Deoxyribonucleic acid
Dihydrofolate reductase
Disease
DNA
Drugs
Edema
Gene expression
Kinases
long‐term survivor
Lung cancer
Medical prognosis
Mesothelioma
non‐squamous non‐small cell lung cancer
Patients
pemetrexed maintenance therapy
Pleural effusion
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Pemetrexed has significant efficacy for some non‐squamous non‐small cell lung cancer cases, as demonstrated in the current case. For those patients, pemetrexed administration should be carefully considered. Pemetrexed has significant efficacy for some non‐squamous non‐small cell lung cancer cases, as demonstrated in the current case. For those patients, pemetrexed administration should be carefully considered.
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.3650